European Early-Stage Seed Investors · Private Equity, VC & Investor
Morningside
Venture capital firm investing in novel science and technology.
Available information varies by company and source.
Profile record updated:
Company facts
- Entity type
- COMPANY
- Founded
- 1986
- Headquarters
- 1188 Centre Street, Newton Centre, MA 02459 (registered/contact address used in SEC filings)
- Company size
- 10–49
- Market cluster / sector
- European Early-Stage Seed Investors
- Market role
- Private Equity, VC & Investor
- Official website
- morningside.com
What Morningside does
Morningside operates as a venture capital investor. It allocates capital into private companies in science- and technology-led sectors, supports portfolio development, and generates returns through equity value creation, follow-on financing, acquisitions and other liquidity events.
Category differentiation
Morningside is a venture capital investment firm, not an operating software vendor, adtech platform or media company. It is distinguished by deploying capital into science and technology businesses rather than selling enterprise products.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Morningside is a private venture capital firm based in Newton, Massachusetts. It invests in companies developing novel science and technology, with stated focus areas including life sciences, digital health, AI, materials and broader technology. The firm creates value by providing capital to early and growth-stage innovation businesses and monetises through investment returns on portfolio appreciation and exits. Its direct customers are founders, management teams and companies seeking venture backing, while its broader stakeholders include the family capital behind the firm and portfolio companies that rely on strategic support and long-term funding.
Business model & monetisation
The firm monetises through investment gains on equity stakes in portfolio companies. Its commercial model is based on venture investing rather than software sales, advertising, subscriptions or transaction processing.
Products & capabilities
No products with linked sources are available in this view.
Unlock Full Intelligence Profile for Morningside
Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.
Verified Ownership & Corporate Hierarchy
Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.
360° Tech Stack & Vendor Telemetry
Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.
Live Market Signals & Executive Briefings
Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Neuroelectrics CEO Ana Maiques to keynote EU-Startups Summit 2027
Event · Recorded impact score: 1/5
Ana Maiques, co-founder and CEO of Barcelona-based neurotechnology company Neuroelectrics, will deliver a keynote at the EU-Startups Summit 2027 in Malta. The summit, scheduled for May 13-14, 2027, is expected to draw around 2,500 attendees. Maiques will share insights on scaling a deep-tech venture from research to global markets, drawing on Neuroelectrics' journey since its 2011 founding. The company raised a €15 million Series A led by Morningside Ventures in 2021 and has expanded its non-invasive brain stimulation technologies to over 74 countries. Maiques is also a co-founder of Starlab and EsTech and serves on the European Innovation Council Advisory Board, advocating for women in STEM.
- Ana Maiques, co-founder and CEO of Neuroelectrics, will speak at the EU-Startups Summit 2027, taking place May 13-14 in Malta.
- Neuroelectrics raised a €15 million Series A in 2021, led by Morningside Ventures.
Explore company relationships
Questions about Morningside
What is Morningside?
Morningside is a private venture capital firm that invests in companies developing novel science and technology.
Who uses Morningside?
Founders and management teams in sectors such as life sciences, digital health, AI, materials and technology seek capital and support from Morningside.
How does Morningside make money?
Morningside makes money through returns on equity investments in portfolio companies, including appreciation and exit proceeds.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
9 publicly documented primary sources and citations linked across the market graph.
Continue your research on Morningside
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.
Unlock full intelligence profile, ownership & live market signals